The antiviral activity of the Gepon piptide immunomodulator in experimental models of street rabies virus

Voprosy Virusologii

Volumn 48, Issue 4, 2003, Pages 40-44

  Gribencha, S V ^a   Holms, R D ^a   Ataullakhanov, R I ^a   Barinsky, I F ^a  

^a NONE

Author keywords

Antiviral activity; Dynamic method of efficiency evaluation; Gepon drug; Street rabies virus

Indexed keywords

ANIMALIA; RABIES VIRUS;

ANTIVIRUS AGENT; IMMUNOLOGICAL ADJUVANT;

ANIMAL; ARTICLE; CHEMISTRY; DISEASE MODEL; DRUG SCREENING; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; RABIES; RABIES VIRUS; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; INJECTIONS, INTRAMUSCULAR; MICE; RABIES; RABIES VIRUS; TREATMENT OUTCOME;

EID: 1542754057     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Arya S. A. Therapeutic failures with rabies vaccine and RIG // Clin. Infect. Dis. - 1999. - Vol. 29, N 6. - P. 1605.
2. Dean D. S., Baer G. M., Thompson W. R. Studies of the local treatment of rabies infected wounds // Bull. Wld Hlth Org. - 1963. - Vol. 28. - P. 477-486.
3. Gacouin A., Bourhy H. et al. Human rabies despite postexposure vaccination // Eur. J. Clin. Microbiol. Infect. Dis. - 1999. - Vol. 18, N 3. - P. 233.
4. Gibbons R. V., Rupprecht C. E. Postexposure rabies prophylaxis in immunosuppressed patients // J. A. M. A. - 2001. - Vol. 285, N 12. - P. 1575-1579.
5. Gribencha S. V., Gribanova L. Ya., Malkov G. B., Barinsky I. F. Population structure of some street rabies virus strains // Arch. Virol. - 1989. - Vol. 104. - P. 347-350.
6. Habel K. Antiserum in the prophylaxis of rabies // Bull. Wld Hlth Org. - 1954. - Vol. 10. - P. 781-788.
7. Harmon M. N., Janis B. Studies of the interferon inducer Poly-I-Poly-C on rabies // J. Infect. Dis. - 1975. - Vol. 132. - P. 241-249.
8. Lang J., Simanjuntak G. N., Soerjasembodo S. et al. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of postexposure rabies vaccination under 2-1-1 regimen: a field trial in Indonesia // Bull. Wld Hlth Org. - 1998. - Vol.'76, N 5. - P. 491-496.
9. Lang J., Gravenstein S., Briggs D. et al. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies // Biologicals. - 1998. - Vol. 26. - P. 7-15.
10. Pancharoen C., Wilde H. Failure of pre- and postexposure rabies vaccination in a child infected with HIV // Scand. J. Infect. Dis. - 2001. - Vol. 33, N 5. - P. 390.
11. Wilde H., Sirikawin S., Sabcharoen A. et al. Failure of postexposure treatment of rabies in children // Clin. Infect. Dis. - 1996. - Vol. 22. - P. 228-232.
12. Wilde H., Tipkong P., Sitprija V., Chaiyabutr N. Heterologus antisera and antivenus are essential biological perspectives on a worldwide crisis // Ann. Intern. Med. - 1996. - Vol. 125, N 3. - P. 233-236.
13. Wilde H., Tipkong P., Khawplod P. Economic issues in postexposure rabies treatment // J. Travel. Med. - 1999. -Vol. 6, N 3. - P. 7-11.